Q4 2022 Rigel Pharmaceuticals Inc Earnings Call Transcript
Greetings, and welcome to Rigel Pharmaceuticals Financial Conference Call for the fourth quarter and year-end 2022. (Operator Instructions). It is now my pleasure to introduce your first speaker, Ray Furey, Rigel's Executive Vice President, General Counsel and Corporate Secretary. Thank you. You may begin.
Hello. Welcome to our fourth quarter and year-end 2022 financial results and business update conference call. The financial press release for the fourth quarter and year-end 2022 was issued a short while ago and can be viewed along with the slides for this presentation in the News and Events section of our Investor Relations site on rigel.com. As a reminder, during today's call, we may make forward-looking statements regarding our financial outlook and our plans and timing for regulatory and product development. These statements are subject to risks and uncertainties that may cause actual results to differ from those forecasted. A description of these risks can
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |